Compare Mutual Funds
Select a Mutual Fund
Risk | Very High | - |
Rating | 2.0 | - |
Min SIP Amount | ₹500 | - |
Expense Ratio | 2.35 | - |
NAV | ₹14.73 | - |
Fund Started | 18 Oct 2021 | - |
Fund Size | ₹223.80 Cr | - |
Exit Load | Exit load of 0.50%, if redeemed within 3 months. | - |
Risk
Very High
-
Rating
2.0
-
Min SIP Amount
₹500
-
Expense Ratio
2.35
-
NAV
₹14.73
-
Fund Started
18 Oct 2021
-
Fund Size
₹223.80 Cr
-
Exit Load
Exit load of 0.50%, if redeemed within 3 months.
-
1 Year | -9.89% | - |
3 Year | 16.63% | - |
5 Year | - | - |
1 Year
-9.89%
-
3 Year
16.63%
-
5 Year
-
-
Equity | 97.89% | - |
Cash | 2.11% | - |
Equity
97.89%
-
Cash
2.11%
-
Top 10 Holdings |
| - |
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 10.91% |
Divi's Laboratories Ltd. | 8.90% |
Apollo Hospitals Enterprise Ltd. | 5.91% |
Max Healthcare Institute Ltd. | 5.64% |
Torrent Pharmaceuticals Ltd. | 4.55% |
Aurobindo Pharma Ltd. | 4.00% |
Fortis Healthcare Ltd. | 3.58% |
Cohance Lifesciences Ltd. | 3.45% |
Lupin Ltd. | 3.40% |
Alkem Laboratories Ltd. | 3.06% |
-
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. | - |
Launch Date | 18 Oct 2021 | - |
Description
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.
-
Launch Date
18 Oct 2021
-